Vanessa Wong

7PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Ngā tikanga mātauranga o te Māori (Māori educational methods)Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 30, 2026
Real-world outcomes in patients with hormone receptor positive, human epidermal growth factor receptor 2 receptor-negative advanced breast cancer and visceral metastases at baseline - advanced hormone receptor positive breast cancer registry in Australia.

|Nov 18, 2024
Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer.

Matthew Loft, Vanessa Wong, Suzanne Kosmider

|Oct 28, 2024
Medicine Access Programmes: what do patients think - a patient-reported outcome study on ribociclib in metastatic breast cancer in Australia.

Natasha Yap, Vanessa Wong, Catherine Morton

|Jun 06, 2022
Compliance with Therapeutic Goods Association prescribing information: weekly or second weekly cetuximab for the treatment of metastatic colorectal cancer.

Matthew Loft, Jeremy Shapiro, Margaret Lee

|Mar 28, 2022
Exploring Survival Outcomes in Metastatic Colorectal Cancer Harboring KRAS A146 Mutations: Important Distinction or Simple Distraction?

Richard Pham, Azim Jalali, Chia Chong

|May 18, 2021
Uptake of bone-modifying agents in patients with HER2+ metastatic breast cancer with bone metastases - prospective data from a multi-site Australian registry.

Vanessa Wong, Richard de Boer, Catherine Dunn

Pageof 2

Frequent Collaborators

2 joint publications

Sheau Wen Lok

2 joint publications

Matthew Loft

1 joint publications

Ian M Collins

1 joint publications

Richard Pham